Work

Current status and new treatment approaches in TP53 mutated AML

Year: 2019
Type: review
Language: English
Subfield: Hematology
Field: Medicine
Open Access status: closed
Funder: Celgene
OpenAlex ID: W2944248311
FWCI: 2.445
Cites: 132
Cited by: 103
Related to: 10